CN1281224C - Cinese medicine increasing leucocyte and preparation thereof - Google Patents

Cinese medicine increasing leucocyte and preparation thereof Download PDF

Info

Publication number
CN1281224C
CN1281224C CN 01127787 CN01127787A CN1281224C CN 1281224 C CN1281224 C CN 1281224C CN 01127787 CN01127787 CN 01127787 CN 01127787 A CN01127787 A CN 01127787A CN 1281224 C CN1281224 C CN 1281224C
Authority
CN
China
Prior art keywords
chinese medicine
parts
ginseng
preparation
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 01127787
Other languages
Chinese (zh)
Other versions
CN1406602A (en
Inventor
成碧春
成海荣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 01127787 priority Critical patent/CN1281224C/en
Publication of CN1406602A publication Critical patent/CN1406602A/en
Application granted granted Critical
Publication of CN1281224C publication Critical patent/CN1281224C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a traditional Chinese medicine capable of increasing leucocyte and a preparation method thereof. The traditional Chinese medicine is prepared from the components of the following parts by weight: 1 to 5 parts of ginseng, 2 to 6 parts of atractylodes rhizome, 3 to 7 parts of rice vineger and 8 to 12 parts of melanterite. The preparation method comprises: firstly, purifying the ginseng and the atractylodes rhizome, drying and pulverizing the ginseng and the atractylodes rhizome into granules of below 120 meshes; then, mixing the melanterite and the rice vineger, calcining and pulverizing the mixture into granules of below 120 meshes; finally, mixing the granules, and uniformly stirring to obtain the traditional Chinese medicine. The traditional Chinese medicine has the advantages of convenience to take, conspicuous curative effect and no toxic or side effect, and is suitable for treating leukopenia of patients with malignant tumors because of chemotherapy and radiotherapy.

Description

A kind of short leukogenic Chinese medicine and manufacture method
Technical field
This invention belongs to the Chinese medicine class, relates in particular to the leukopenia that treatment causes by radiotherapy, chemotherapy and the Chinese medicine (the white spirit of ginseng) of agranulocytosis) and manufacture method.
Background technology
Radiotherapy, chemotherapy are generally acknowledged by medical circle already as one of main method for the treatment of malignant tumor.But the serious toxic and side effects of bringing after radiotherapy, the chemotherapy, as nausea and vomiting, anorexia, oral cavity and esophageal ulcer etc., make the patient be difficult to stand and adhere to, the leukopenia and the agranulocytosis that cause of particularly radiotherapy, chemotherapy wherein, this serious toxic and side effects, so far still fail to solve, the patient often is forced to end to put, chemotherapy treatment, has therefore influenced curative effect and patient's life span greatly.How to urge to give birth to leukocyte, become a very important problem finishing radiotherapy, chemotherapy regimen for the patient.
The leukopenia that radiotherapy, chemotherapy cause, can cause severe infections, even cause death, to this serious consequence, use CSF (gene recombinaton granulocyte colony-stimulating factor) to impel hemopoietic granulocyte differentiation and proliferation clinically usually, stimulating granulocyte to grow up discharges, the granulocyte of blood prevents severe infections around increasing, and causes the reduction mortality rate to reach, use its curative effect of CSF reliable, but following shortcoming is arranged: 1) to M 3Type leukaemic can not use; 2) certain side effect is arranged, can not use as allergy sufferers; 3) be injection-type in the use, can bring misery to the patient; 4) most scholars think leukemia not the effector should not use promote the growth effect because CSF juvenile white cell to Leukemia Patients equally also has, can cause leukemia relapse or increase the weight of the state of an illness.
Summary of the invention
Purpose of the present invention is exactly in order to address the above problem, and a kind of short leukogenic Chinese medicine and manufacture method are provided.
A kind of short leukogenic Chinese medicine is characterized in that: by weight, made by Radix Ginseng 1-5 part, Rhizoma Atractylodis 2-6 part, rice vinegar 3-7 part, ferrosisuifas crudus 8-12 part.
The manufacture method of above-mentioned Chinese medicine is characterized in that: by proportioning, get Radix Ginseng, Rhizoma Atractylodis earlier, after the purification, dry, be ground into the following granule of 120 orders; Ferrosisuifas crudus is mixed with rice vinegar, after the calcination, be ground into the following granule of 120 orders, mix with aforementioned particles again and mix thoroughly.
Produced according to the method described above Chinese medicine (the white spirit of ginseng) has the recovery of the marrow function of promotion and strengthens hemopoietic function, has the short rapidly leukocytic effect that rises, to better curative effect being arranged because of the concurrent severe infections of leukopenia, heating, also can control rapidly and cure infection, make body temperature recover normal naturally.To because of the bone marrow depression of putting, chemotherapy causes, cause erythrocyte to reduce and thrombocytopenia, the patient who presents serious anemia and bleeding clinically, have curative effect equally, can make erythrocyte, hemoglobin, platelet increase sharply, anemia and bleeding are eliminated, increase the oxygen content of blood, the patient is had rosy cheeks, breathe freely suitablely, muscle power strengthens.
Radiotherapy, chemotherapy take simultaneously Chinese medicine provided by the invention can make put, patients undergoing chemotherapy finishes chemotherapy regimen smoothly, thereby improve curative effect, to Leukemia Patients particularly remarkable because of leukopenia and the agranulocytosis that chemotherapy causes.
Chinese medicine provided by the invention has the effect of human body immunity improving power.
Chinese medicine provided by the invention has no side effect, and is oral capsule in the use, and determined curative effect is reliable, and no pain can replace the use of CSF.
The specific embodiment
By weight, get Radix Ginseng 100 grams, Rhizoma Atractylodis 500 grams, rice vinegar 500 grams, ferrosisuifas crudus 900 grams purify Radix Ginseng, Rhizoma Atractylodis earlier, dry, are ground into the following granule of 120 orders; Again ferrosisuifas crudus is mixed with rice vinegar, after the calcination, be ground into the following granule of 120 orders, mix to mix thoroughly with aforementioned particles then and make.
The above-mentioned Chinese medicine of making is made honeyed pill or tablet or capsule, make every honeyed pill or tablet or capsule contain 525 milligrams in above-mentioned medicated powder, packing gets final product.
The zoopery of doing through Hong Kong Chinese University: give mice feed every day " the white spirit of ginseng " 5mg, after three days, measure the expression character of different mouse spleen cell mRNA (information nucleic acid), found that: the interleukin-11-α of experimental mouse (1L-1 alpha) exceeds four times than matched group, interleukin-11 3 (1L-13) exceeds three times than matched group, and stem cell factor (SCF) exceeds twice than matched group.
The biologic activity of interleukin-11 (1L-1): 1) promote thymocyte cell, T cell activation propagation and differentiation; 2) enhanced CT L (cytotoxic T lymphocyte) and NK's (natural killer cell) is lethal; 3) collaborative 1L-4 stimulates B cell proliferation, the generation of differentiation and immune globulin (1g); 4) collaborative CSF promotes hemopoietic function; 5) stimulate stem cell to produce stem cell factor (S.C.F).
The biologic activity of interleukin-11 3 (1L-13): 1) stimulate B cell proliferation and CD23 to express, induce the B cell produce immunoglobulin (lgM, lgG, lgE); 2) induce large granular lymphocyte (L.G L) to produce interferon r (IFN-r); 3) suppressing monokaryon---the struvite cytokine of macrophage produces.
From above-mentioned zoopery, confirm the effect that " the white spirit of ginseng " has human body immunity improving power really.Put, chemotherapy takes " ginseng white spirit " clinical observation finding simultaneously:
1) can obviously alleviate gastrointestinal reaction, eliminate nausea and vomiting, appetite strengthening makes weight increase, and body constitution strengthens.
2) generation of control oral cavity and esophageal ulcer, the original oral ulcer of patient also can heal rapidly.
3) significantly reduce the incidence rate of alopecia.
Clearly, put, the chemotherapy patients proves in the clinical observation of taking " ginseng white spirit ", because immunocompetence improves, resistance strengthens, and puts, the toxic and side effects of chemotherapy just greatly reduces, and health status is significantly improved, the life quality obviously improves, and helps further putting, the enforcement of chemotherapy regimen.

Claims (2)

1, a kind of short leukogenic Chinese medicine is characterized in that: by weight, by Radix Ginseng 1-5 part, Rhizoma Atractylodis 2-6 part, rice vinegar 3-7 part, ferrosisuifas crudus 8-12 part is made.
2, the manufacture method of Chinese medicine according to claim 1 is characterized in that: by the described proportioning of claim 1, get Radix Ginseng, Rhizoma Atractylodis earlier, after the purification, dry, be ground into the following granule of 120 orders; Ferrosisuifas crudus is mixed with rice vinegar, after the calcination, be ground into the following granule of 120 orders, mix with aforementioned particles again and mix thoroughly.
CN 01127787 2001-08-28 2001-08-28 Cinese medicine increasing leucocyte and preparation thereof Expired - Fee Related CN1281224C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 01127787 CN1281224C (en) 2001-08-28 2001-08-28 Cinese medicine increasing leucocyte and preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 01127787 CN1281224C (en) 2001-08-28 2001-08-28 Cinese medicine increasing leucocyte and preparation thereof

Publications (2)

Publication Number Publication Date
CN1406602A CN1406602A (en) 2003-04-02
CN1281224C true CN1281224C (en) 2006-10-25

Family

ID=4667701

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 01127787 Expired - Fee Related CN1281224C (en) 2001-08-28 2001-08-28 Cinese medicine increasing leucocyte and preparation thereof

Country Status (1)

Country Link
CN (1) CN1281224C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW591528B (en) 2002-05-01 2004-06-11 Prolific Technology Inc Plug-and-play device and access control method thereof
CN107510821A (en) * 2017-10-27 2017-12-26 刘萍 A kind of medicine for treating leukopenia and preparation method thereof

Also Published As

Publication number Publication date
CN1406602A (en) 2003-04-02

Similar Documents

Publication Publication Date Title
US6030622A (en) Herbal extract composition and method with immune-boosting capability
CN1903280A (en) Yukangsan herb medicine powder for treating fish diseases
CN103505679B (en) Drug for treating blood diseases, preparation method, and applications thereof
CN1733136A (en) Medicine for invigorating qi and nourishing blood comprising donkey-hid gelatin and angelica and process for preparing the same
CN102961636B (en) Pure traditional Chinese medicine composition for treating poultry infectious bursal disease and preparation method thereof
CN1281224C (en) Cinese medicine increasing leucocyte and preparation thereof
CN1177598C (en) Medicine for eliminating side effect of radiotherapy and chemotherapy to treat malignant tumor and its prepn
CN1162172C (en) Baixue-Genzhi-Changshoubao-Chinese medicine for treating leukemia and concurrently treating aplastic anemia
Li et al. Effects of traditional Chinese herbal medicines on blood cell count and immunity in chickens
CN1376472A (en) Medicine for treating aplastic anemia and its preapring process
CN114588214B (en) Composition and granules for improving bone marrow suppression after chemotherapy and preparation method
CN115317554B (en) Traditional Chinese medicine composition for treating neutrophil deficiency with fever after chemotherapy and preparation method thereof
CN103127391B (en) Drug for curing blood diseases and preparation method thereof
CN1059590C (en) Medicine for blood generation and preparing method
CN1273172C (en) Medicine for treating chronic colonitis
CN1186036C (en) Diabetes treating medicine and its prepn
CN102475825A (en) Spleen-tonifying and blood-enriching pill
CN104906542A (en) Traditional Chinese medicine composition for treating canine coronavirus infection and preparation method of traditional Chinese medicine composition
CN102475880A (en) Qi-benefiting and blood-nourishing tablets
CN102793896A (en) Membranous milkvetch root and pilose Asiabell root tablet
CN1135999C (en) Medicine for curing chicken disease of respiratory tract
CN117357627A (en) Composite medicine for improving body immunity of poultry and preparation method and application thereof
CN1331995A (en) Chinese medicine composition for treating lung cancer
CN1277570C (en) Pharmaceutical for treating alimentary tract ulcer disease and preparing process thereof
CN106924404A (en) Treat Chinese medicine composition of chicken gastroenteritis and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Cheng Hairong

Document name: Notification of registration

C14 Grant of patent or utility model
GR01 Patent grant
C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Cheng Hairong

Document name: Notice of patent for invention

C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Cheng Hairong

Document name: Notification to Pay the Fees

C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Cheng Hairong

Document name: Resumption of patent approval decision

DD01 Delivery of document by public notice

Addressee: Cheng Hairong

Document name: Notification to Pay the Fees

DD01 Delivery of document by public notice

Addressee: Cheng Hairong

Document name: Notification of Termination of Patent Right

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20061025

Termination date: 20110828